Processing
Collecting data for STEM

StemCells Inc  

    
$0.6749
Change

0.03

  

4.14%

10 Days Price Trend
May 28, 2015 
Highest Price  
Lowest Price  
May 22, 2015 
May 5, 2015 

StemCells Market Sensitivity

StemCells Inc Market Cap Over Time

SymbolSTEM
ISINUS085857R200
CUSIP085857R20
NameStemCells Inc
InstrumentUSA Stock
SectorHealthcare
IndustryBiotechnology
BenchmarkNYSE
Websitehttp://www.stemcellsinc.com
Contact Number510 456 4000
Analyst ConsensusStrong Buy 4 Opinions
Risk-adjusted AdviceStrong Sell Under Valued
CurrencyUSD - US Dollar
ExchangeNasdaq Capital Markets
DescriptionStemCells Inc. a biopharmaceutical company researches develops and commercializes cellbased therapeutics and related technologies for stem cellbased research and drug discovery and development. more
Return On Asset(52.23) %
Price to Book7.29 times
Price to Sales42.43 times
Compare to Competition   Compare Correlations

StemCells Leadership

Martin McGlynn CEO, Director, CEO of Stemcells California Inc and President of Stemcells California Inc and Member of Strategic Transactions Committee
John Schwartz Independent Chairman of the Board, Ph.D

StemCells Diversification Suggestion

Use StemCells to enhance returns of your portfolios. The stock experiences very speculative upward sentiment.. Check odds of StemCells to be traded at $0.8436 in 30 days

StemCells Daily Price Distribution

The median price of StemCells for the period between Tue, Apr 28, 2015 and Thu, May 28, 2015 is 0.62 with a coefficient of variation of 3.78. The daily time series for the period is distributed with a sample standard deviation of 0.02, arithmetic mean of 0.62, and mean deviation of 0.02. The Stock received some media coverage during the period.

StemCells Summary

StemCells Inc [STEM] is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 69 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 43.65 M. StemCells Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 69.29 M outstanding shares of which 2 M shares are at this time shorted by private and institutional investors with about 2.5 trading days to cover.

StemCells Inc Accumulated Other Comprehensive Income Over Time

StemCells Alerts

StemCells Inc has some characteristics of a very speculative penny stock
StemCells Inc has very high historical volatility over the last 30 days
StemCells Inc has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 1.01 M. Net Loss for the year was (32.26 M) with profit before overhead, payroll, taxes, and interest of 1.01 M.
STEMCELLS INC currently holds about 24.99 M in cash with (27.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36.
Roughly 24.0% of the company outstanding shares are owned by corporate insiders

StemCells upcoming events

Upcoming Quarterly ReportAugust 11, 2015
Next Earnings ReportNovember 4, 2015

StemCells Earnings Estimates

EPSEstimate Date
Quarterly Estimate-0.1August 11, 2015
StemCells Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
StemCells Earnings Estimate  

StemCells Analyst Recommendations

Target PriceConsensus AdviceNumber of Analysts
2.387Strong Buy4
StemCells Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
StemCells Analyst Recommendations  

StemCells Research Report

Get StemCells research report. Reports are available in pdf format and contain fundamental information about the equity. Click Generate StemCells report to view

StemCells Pair Trading Analysis

Correlation analysis and pair trading evaluation for StemCells and Gilead Sciences. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run pair correlation  

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Macroaxis investing theme could easily outperform a given market if properly optimized
Explore Investing Ideas  

StemCells Directors

Irving Weissman Director
Eric Bjerkholt Independent Director
R Greer Independent Director
Ricardo Levy Independent Director
Alan Trounson Director

StemCells Fundamentals Correlation

Short Ratio vs Price to Sales
Debt to Equity vs Total Asset
Short Ratio vs Working Capital

StemCells vs Competition

StemCells vs. Gilead Sciences Inc
StemCells vs. Amgen Inc
StemCells vs. Biogen Idec Inc
StemCells vs. Celgene Corporation
StemCells vs. Regeneron Pharmaceuticals Inc
StemCells vs. Alexion Pharmaceuticals Inc
StemCells vs. Vertex Pharmaceuticals Incorporated
StemCells vs. Illumina Inc
StemCells vs. Pharmacyclics Inc
StemCells vs. BioMarin Pharmaceutical Inc

StemCells May 28, 2015 Opportunity Range

Information Ratio0.1517
Maximum Drawdown15.89
Value At Risk(3.28)